5-chloromethylfluorescein diacetate has been researched along with protoapigenone in 1 studies
| Studies (5-chloromethylfluorescein diacetate) | Trials (5-chloromethylfluorescein diacetate) | Recent Studies (post-2010) (5-chloromethylfluorescein diacetate) | Studies (protoapigenone) | Trials (protoapigenone) | Recent Studies (post-2010) (protoapigenone) |
|---|---|---|---|---|---|
| 107 | 0 | 38 | 29 | 0 | 18 |
| Protein | Taxonomy | 5-chloromethylfluorescein diacetate (IC50) | protoapigenone (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 3.84 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 2.58 | |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baell, JB; Board, PG; Casarotto, MG; Dahlin, JL; Oakley, AJ; Xie, Y | 1 |
1 review(s) available for 5-chloromethylfluorescein diacetate and protoapigenone
| Article | Year |
|---|---|
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
Topics: Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorescence Polarization; Glutathione Transferase; Humans | 2018 |